IP Library › Granted Patent US 11,185,511
Granted Patent B2
US 11,185,511 · App. 15/023,602 · Granted Nov 30, 2021

Antifungal topical composition and methods of treatment

Inventors: John Ridden (Macclesfield, GB); Michael Davies (Macclesfield, GB); Liam Good (London, GB)
Assignee: BLUEBERRY THERAPEUTICS LIMITED
A61K9/5146A61K9/0014A61K9/0021A61K9/5123A61K31/137A61K31/4745A61K31/496A61K31/7048A61M37/0015A61M2037/0023
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,185,511
App. No.
15/023,602
Granted
Nov 30, 2021
Kind
B2
Abstract

The present invention relates to a topical composition (and methods of producing the such compositions) for the treatment of a fungal infection comprising a polymer capable of forming nanoparticles and an antifungal agent. The invention also relates to novel uses of polyhexamethylene biguanide.

Claims (9)

1. A topical composition for the treatment of a fungal nail or skin infection comprising nanoparticles comprising a polymer and an antifungal agent, wherein the polymer comprises polyhexamethylene biguanide and the antifungal agent comprises terbinafine, wherein a ratio of the polyhexamethylene biguanide to terbinafine is about 3:1.

2. A topical composition as claimed in claim 1 , wherein the antifungal agent is present in a dosage amount within the composition, which is less than the therapeutically effective systemic dose of the antifungal agent.

3. A topical composition as claimed in claim 1 , wherein the composition further comprises one or more of the following component: buffers, excipients, binders, oils, water, emulsifiers, glycerin, antioxidants, preservatives and fragrances.

4. A topical composition as claimed in claim 3 , wherein the composition further comprises urea.

5. A topical composition as claimed in claim 1 , wherein the fungal skin infection comprises athlete's foot.

6. A topical composition as claimed in claim 1 , wherein the antifungal agent comprises one or more further agents selected from the following group: Nystatin, Ketoconazole, Amphotericin B, Itraconazole or Berberine.

7. A topical composition as claimed in claim 1 , wherein the fungal infection comprises a dermatophytic and/or yeast infection.

8. A topical composition as claimed in claim 1 , wherein the composition is in the form of a cream, ointment, spray or powder.

9. The topical composition as claimed in claim 1 , wherein the composition is present in a solution in which the concentration of PHMB is 3 μg/ml and the concentration of terbinafine is 1 g/ml.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2016
From: RIDDEN, JOHN; DAVIES, MICHAEL; GOOD, LIAM
To: BLUEBERRY THERAPEUTICS LIMITED
Reel/Frame 039560/0660 →
Priority Claims (2)
GB 1317005 · Sep 25, 2013 · national
GB 1320723 · Nov 25, 2013 · national
Continuity (1)
Related Publication 20160206567A1 · Jul 21, 2016